An estimated 16 Million Americans suffer from rosacea, and about 24% of them say that persistent facial redness was their first symptom. The redness is caused by dilated blood vessels, and while it varies day to day, it can be a bit hard to deal with. Usually, this results in covering it up with makeup, 77% of those with rosacea wear makeup compared to 53% of everyone else.
Mirvaso® (brimonidine) topical gel, 0.33%*, a prescription drug that treats the persistent facial redness of rosacea, has created a website with information about rosacea with great skincare tips from NYC dermatologist Dr. Doris Day. I found her tips to be very helpful; she recommends specific ingredients to look for in your skincare products.
While you’re checking out the website you can also enter for a chance to win a trip to the Emmy’s!
Mirvaso is a prescription drug and you’ll need to see your doctor (remember, I’m a doctor, but I’m not your doctor!) to discuss whether it is a good option for you.
Important Safety Information Indication: Mirvaso® (brimonidine) topical gel, 0.33%* is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.